Patients with coronary artery disease and an indication for PCI research hub

COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study

This study looks at two common blood-thinning medications, Ticagrelor (Brilique) and Clopidogrel, in patients with heart artery disease undergoing a procedure to widen their arteries (PCI). It explores how effective and safe these drugs are, especially when a genetic test might help guide which one to use.